ME/CFS Evidence Browser — Classified Studies on Myalgic Encephalomyelitis

141–160 of 1,205 studies

Intermittent and graded exercise effects on NK cell degranulation markers LAMP-1/LAMP-2 and CD8+CD38+ in chronic fatigue syndrome/myalgic encephalomyelitis.

Broadbent, Suzanne, Coutts, Rosanne·Physiological reports·2017

This study tested whether two types of exercise programs could help improve immune system function in ME/CFS patients. Twenty-four ME/CFS patients were assigned to either graded exercise, intermittent exercise, or usual care, and researchers measured specific immune cells before and after 12 weeks. Both exercise programs increased markers of natural killer cell activity without making symptoms worse, and improved patients' exercise capacity.

Evidence Atlas

Evidence browser

Intermittent and graded exercise effects on NK cell degranulation markers LAMP-1/LAMP-2 and CD8+CD38+ in chronic fatigue syndrome/myalgic encephalomyelitis.

Graded versus Intermittent Exercise Effects on Lymphocytes in Chronic Fatigue Syndrome.

Investigating neural mechanisms of change of cognitive behavioural therapy for chronic fatigue syndrome: a randomized controlled trial.

Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut.

Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome.

[Impacts on chronic fatigue syndrome of qi deficiency syndrome and T cell subgroups in patients treated with acupuncture at selective time].

Effects of the intelligent-turtle massage on the physical symptoms and immune functions in patients with chronic fatigue syndrome.

[Effect of lixu jieyu recipe in treating 75 patients with chronic fatigue syndrome].

A placebo-controlled, double-blind, randomized controlled trial of a natural killer cell stimulant (BioBran MGN-3) in chronic fatigue syndrome.

Immune modulation with a staphylococcal preparation in fibromyalgia/chronic fatigue syndrome: relation between antibody levels and clinical improvement.

Treatment with staphylococcus toxoid in fibromyalgia/chronic fatigue syndrome--a randomised controlled trial.

Lymphocyte markers and natural killer cell activity in fibromyalgia syndrome: effects of low-dose, sublingual use of human interferon-alpha.

Consequences of live poliovirus vaccine administration in chronic fatigue syndrome.

Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome.

Clinical improvement in chronic fatigue syndrome is not associated with lymphocyte subsets of function or activation.

Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome.

alpha-Interferon treatment of patients with chronic fatigue syndrome.

Lessons from a pilot study of transfer factor in chronic fatigue syndrome.

Changes in the 2-5A synthetase/RNase L antiviral pathway in a controlled clinical trial with poly(I)-poly(C12U) in chronic fatigue syndrome.

A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome.

Curated Collections

Neuroinflammation Evidence

Metabolism & Mitochondria

Biomarkers

PEM-Specific Research